Capital World Investors’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,122,400
| Closed | -$202M | – | 534 |
|
|
2017
Q3 | $202M | Sell |
1,122,400
-1,448,000
| -56% | -$202M | 0.05% | 234 |
|
|
2017
Q2 | $266M | Buy |
2,570,400
+153,400
| +6% | +$12.5M | 0.06% | 200 |
|
|
2017
Q1 | $190M | Buy |
2,417,000
+592,000
| +32% | +$36.6M | 0.05% | 229 |
|
|
2016
Q4 | $81.8M | Buy |
1,825,000
+266,000
| +17% | +$13M | 0.02% | 291 |
|
|
2016
Q3 | $87.1M | Buy |
1,559,000
+36,000
| +2% | +$2.01M | 0.02% | 291 |
|
|
2016
Q2 | $76.2M | Buy |
1,523,000
+483,000
| +46% | +$23.7M | 0.02% | 302 |
|
|
2016
Q1 | $47.7M | Sell |
1,040,000
-256,000
| -20% | -$12.4M | 0.01% | 334 |
|
|
2015
Q4 | $79.9M | Hold |
1,296,000
| – | – | 0.02% | 305 |
|
|
2015
Q3 | $72.2M | Sell |
1,296,000
-22,000
| -2% | -$1.38M | 0.02% | 312 |
|
|
2015
Q2 | $80.4M | Buy |
1,318,000
+40,000
| +3% | +$2.28M | 0.02% | 322 |
|
|
2015
Q1 | $73.7M | Buy |
1,278,000
+532,000
| +71% | +$35.7M | 0.02% | 324 |
|
|
2014
Q4 | $43M | Buy |
746,000
+556,000
| +293% | +$23.4M | 0.01% | 381 |
|
|
2014
Q3 | $5.42M | Buy |
+190,000
| New | +$4.7M | ﹤0.01% | 497 |
|
Capital World Investors's KITE Position: Q4 2017 in Review
Capital World Investors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,122,400 shares — an estimated $202M sold.
Capital World Investors first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $266M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Capital World Investors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Capital World Investors sold 1,122,400 Kite Pharma, Inc. shares in Q4 2017, an estimated $202M.
- Capital World Investors first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
- Capital World Investors's Kite Pharma, Inc. position peaked at $266M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Capital World Investors's 13F filing for Q4 2017, filed 14 Feb 2018.